MTOR and cancer: In this study, our CaP-RR cells with induced EMT and enriched CSCs7 could be successfully treated with combination of dual PI3K/mTOR inhibitors and RT, suggesting that this combination therapy may target CSCs (‘root' of cancer recurrence) to overcome radioresistance and prevent metastasis.